Pricing group says weight-loss drugs becoming more cost-effective
By Deena Beasley (Reuters) – An influential drug pricing watchdog on Tuesday said popular GLP-1 weight-loss injections have become more cost-effective as their prices have fallen and studies have shown proof of their cardiovascular health benefits. In a draft report, the Institute for Clinical and Economic Review gave its highest cost-effectiveness rating to both Novo …
Pricing group says weight-loss drugs becoming more cost-effective Read More »










